Logo Image
News
OncClubAll Oncology NewsClinical Trials in Focus
Media
InsightsMedNews WeekOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid ReadoutsShorts
Conferences
Conference CoverageConference Listing
Events
Giants of Cancer CareCME/CEScientific InterchangesState of the Science SummitNational Fellows ForumWebinars
More
Partners
Publications
All PublicationsSupplements
Resources
Consensus ViewpointsOncLive AppInteractive ToolsSponsored
Biomarker Consortium

Subscribe

  • News
  • Media
  • Conferences
  • Events
  • Partners
  • Publications
  • Resources
  • Biomarker Consortium
  • Subscribe
  • AI for Oncology
  • Biosimilars
  • Brain Cancer
  • Breast Cancer
    • HER2+ Breast Cancer
  • CAR T-Cell Therapy
  • Disparities in Cancer Care
  • Gastrointestinal Cancer
    • Pancreatic Cancer
    • Hepatocellular Carcinoma
    • Gastric Cancer
    • Colorectal Cancer
  • Genitourinary Cancers
    • Urothelial Cancer
    • Prostate Cancer
  • Global Oncology
  • Graft-vs-Host Disease
  • Gynecologic Oncology
    • Ovarian Cancer
  • Head & Neck Cancers
  • Hematologic Oncology
    • Chronic Lymphocytic Leukemia
    • Non-Hodgkin Lymphoma
    • Mantle Cell Lymphoma
    • Multiple Myeloma
    • Myeloproliferative Neoplasms
  • Immuno-Oncology
  • Lung Cancer
  • Melanoma & Skin Cancer
  • Oncology Business Management
  • Pediatric Oncology
  • Precision Medicine in Oncology®
  • Sarcomas
  • Supportive Care
Spotlight -
The OncLive Insider app is live!|
CME Opportunities
Advertisement

Recent Advances in Treatment of Acute Myeloid Leukemia

EP. 1: Molecular Testing for AML

January 28th 2020

EP. 2: AML Induction Strategy and Molecular Testing

January 28th 2020

EP. 3: Assessment of Fitness for AML Induction Chemotherapy

January 28th 2020

EP. 4: Decision Making on Consolidation Therapy for AML

January 28th 2020

EP. 5: QUAZAR: Oral Azacitidine Maintenance in AML

January 28th 2020

EP. 6: Hypomethylating Agents for AML

January 28th 2020

EP. 7: Venetoclax-Based Regimens for Unfit Patients with AML

January 28th 2020

EP. 8: Managing Venetoclax-Associated Toxicity in AML

January 28th 2020

EP. 9: Venetoclax-Based Chemotherapy Combinations in AML

January 28th 2020

EP. 10: CPX-351 for Secondary AML

January 28th 2020

EP. 11: Previously Untreated FLT3-Mutated AML

January 28th 2020

EP. 12: Second-Generation FLT3 Inhibitors for AML

January 28th 2020

EP. 13: Relapsed/Refractory FLT3-Mutated AML

January 28th 2020

EP. 14: IDH1/2 Inhibitors in AML

January 28th 2020

EP. 15: Differentiation Syndrome and IDH1/2 Inhibitors

January 28th 2020

EP. 16: Gemtuzumab Ozogamicin for CD33+ AML and APL

January 28th 2020

EP. 17: Immune Checkpoint Inhibitors for AML

January 28th 2020

EP. 18: Novel Agents Under Investigation for AML

January 28th 2020
Advertisement
Advertisement

Trending on OncLive

1

International Intel: A Glance at the Top Global Breast Cancer News From April-June 2026

2

Pembrolizumab Monotherapy Improves PFS vs Chemotherapy in Frontline dMMR Endometrial Cancer

3

Neoadjuvant Cemiplimab Elicits Responses and Surgical Benefit in HHI-Naive BCC of the Head and Neck

4

Experts Unpack Crucial Hematologic Oncology Data From ASCO 2026

5

CAR T-Cell Engineering Produces Early Efficacy Signals in Glioblastoma

  • Advertise
  • About OncLive
  • Editorial Board
  • MJH Life Sciences brands
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo
Download on Apple
Download on Google Play

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us